Promising ultrasound therapy for Alzheimer’s disease licensed to new start-up

A promising ultrasound therapy to potentially restore brain function in people with Alzheimer’s disease has been licenced to a new start-up spun out of The University of Queensland.

Actemra Biosimilar Approved

The FDA has approved the first biosimilar version of the interleukin-6 (IL-6) blocker tocilizumab, to be marketed as Tofidence and with indications for rheumatoid arthritis

October 4, 2023

Ultragenyx gene therapy for rare liver ailment succeeds in late-stage trial

Ultragenyx said Thursday afternoon that its gene therapy for a rare liver ailment, glycogen disease type 1A, succeeded in a Phase 3 trial, setting up

May 30, 2024

Cue Health’s Covid-19 tests could give false results, FDA warns

The Food and Drug Administration warned consumers Monday to not use Cue Health’s at-home Covid-19 tests. This follows an FDA warning letter to the company

May 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.